Senestech (SNES) vs. Its Competitors Financial Survey

Senestech (NASDAQ:SNES) is one of 296 publicly-traded companies in the “Chemicals” industry, but how does it weigh in compared to its peers? We will compare Senestech to related companies based on the strength of its profitability, analyst recommendations, dividends, risk, earnings, institutional ownership and valuation.

Analyst Ratings

This is a breakdown of current ratings and price targets for Senestech and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senestech	1	0	0	0	1.00
Senestech Competitors	3273	12243	14159	521	2.40

As a group, “Chemicals” companies have a potential upside of 7.61%. Given Senestech’s peers stronger consensus rating and higher probable upside, analysts clearly believe Senestech has less favorable growth aspects than its peers.

Risk & Volatility

Senestech has a beta of 0.11, suggesting that its share price is 89% less volatile than the S&P 500. Comparatively, Senestech’s peers have a beta of 1.09, suggesting that their average share price is 9% more volatile than the S&P 500.

Profitability

This table compares Senestech and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Senestech	-275.26%	-88.62%	-62.01%
Senestech Competitors	-54.13%	-0.60%	-1.36%

Earnings & Valuation

This table compares Senestech and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Senestech	$2.78 million	-$6.38 million	-0.59
Senestech Competitors	$6.37 billion	$229.42 million	19.87

Senestech’s peers have higher revenue and earnings than Senestech. Senestech is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

5.2% of Senestech shares are owned by institutional investors. Comparatively, 47.4% of shares of all “Chemicals” companies are owned by institutional investors. 2.2% of Senestech shares are owned by insiders. Comparatively, 13.7% of shares of all “Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Senestech peers beat Senestech on 13 of the 13 factors compared.

Senestech Company Profile

SenesTech, Inc. is a biotechnology company focused on developing fertility-control technologies for managing animal populations. The company’s approach is designed to reduce reproduction rather than rely solely on lethal control methods, with applications primarily in rodent management. SenesTech’s principal product is ContraPest, a liquid bait designed to reduce fertility in rats by affecting reproductive function in both male and female animals. The product is intended for use in commercial, municipal and other settings where rat populations pose sanitation, health or property risks.